Company intelligence / Profile preview

Earable Neuroscience

Boulder, Colorado, United Statesfrenzband.com ↗

Ownership: Private
Development stage: Commercial

Overview

Earable Neuroscience has commercialized the FRENZ Brainband—a wearable headband that uses AI to track brain activity and deliver personalized audio-based cognitive behavioral therapy to improve sleep. Clinical studies show up to a ~95% accuracy in seizure detection compared to gold-standard EEG. The company partners with academic institutions and pharmaceutical companies for research into epilepsy monitoring and pain biomarker discovery. The product has won multiple CES Innovation Awards.

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy (CBT-I audio therapy)Digital biomarker platform
Industry: Physiological Monitoring

Partnerships

University of Massachusetts (epilepsy research)Regeneron (pain drug discovery)Clevai EdTechBaloo weighted blankets provider

Beyond the preview

Go deeper on Earable Neuroscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Earable Neuroscience.

Explore the full profile